Chapter 1588 The first international title

PreviousBack to directoryNext
 Dr. M chased him to the capital and actually met Liu Miqiao.

Liu Muqiao is not hiding from anyone.

Dr. M is very grateful to Liu Miqiao for the interview.

"I am very, very, very grateful. Dr. Liu, you are one of the most outstanding medical scientists of our time. Your contribution to mankind is huge..."

Don’t think that Chinese people can flatter you. Foreigners can flatter you just as well, or even worse.

After a lot of compliments, he changed the topic and said: "The Obesity Professional Committee would like to ask you to be the deputy chairman and would like to hear your opinions."

When I heard that this was the case, I refused. It’s a pity that we occupy too few seats on this kind of international professional committee. Even for tuberculosis, a major in which we are far ahead in research in the world, we only have one among the chairpersons.

Standing Committee.

However, Liu Muqiao himself is not willing to be the deputy chairman, even if he is the chairman, he is not willing to do it.

So he said: "You can choose Yuan Shan to be the deputy chairman. She is the most accomplished in this field, but I can't."

He recommended Yuan Shan.

Dr. M did not refuse, but he would not agree easily. You must know that the chairman and deputy chairman of the International Academic Committee have a very high status, even higher than the national academicians.

This position will not be given easily, not to mention that you are an Oriental in a country that used to be dominated by traditional Chinese medicine.

He made conditions.

"Dr. Liu, I hope you will publish an article in our journal." Dr. M made a condition.

Liu Muqiao chuckled and said, "Is this the condition for Yuan Shan to serve as deputy chairman?"

"No. However, it can also mean that our principle is mutually beneficial cooperation. What do you think?" Dr. M smiled dryly.

"I used to admire "The Lancet". But, you rejected me." Liu Maqiao is not a person who does not bear grudges. He must remember the grudges that should be remembered.

"It's all over." Dr. M said.

"But I'm not forgetful." Liu Muqiao reminded Dr. M.

"I'm sorry, we are under pressure from the board of directors. You know, we are just employees." Dr. M said.

"This visit is also based on the opinion of the board of directors?" Liu Muqiao asked.

"Yes, the board of directors realized how serious the mistake was."

Dr. M also admitted that without Liu Muqiao's paper, "The Lancet" would lose more than 10 million US dollars every year, and it would fall to third place in the world's journal rankings.

The first place is the "China" journal.

It is unimaginable to return to China for 3 or 5 years.

"The Lancet" has always been hovering among the top two, but now it has fallen to third place.

Don't look at first place and third place, there is not much difference. You must know that for enterprising people, first place is the eternal goal they pursue. Just like athletes, the champion is the winner.

"The Lancet" ranked third, which is absolutely a shame.

In fact, Liu Muqiao does not have a deep hatred for "The Lancet". "BMJ", "NEJM", and "JAMA" are what Liu Muqiao is most angry about.

Liu Muqiao smiled.

Is it enough to know the error?

"Dr. Liu, for your paper, we will reward you with the highest remuneration. We hope for your cooperation." Dr. M began to play his trump card.

He offered $100 per word.

This is an unprecedented remuneration. 10,000 words equals 1 million US dollars.

Unexpectedly, Liu Muqiao shook his head.

"You..."

Dr. M was about to cry. This price is really sky-high. No Nobel Prize winner has ever offered this price. The most recent one was last year’s Nobel Prize winner. One paper offered a price of 50 US dollars per word.

"Dr. Liu, this is our greatest sincerity at The Lancet."

"Dr. M, thank you for your sincerity, but I can consider that in the future, my papers as the advisor can be published in your journal. The condition is that Yuan Shan serves as the vice president of the Obesity Professional Society."

Liu Muqiao finally gave in.

Yuan Shan's last paper was not signed by Liu Miqiao's name, nor even the name of her supervisor. There were only three characters Liu Miqiao in her thank you speech.

Dr. M nodded excitedly.

This is already a great progress, which means that Liu Miqiao no longer rejects "The Lancet".

"Can't we cooperate further?" Dr. M asked.

Liu Muqiao shook his head.

It’s not that he has trouble with money, $100 per word is really a sky-high price, and publishing tens of thousands of words in The Lancet a year is an income of millions of dollars. For someone else, the temptation would be very great.
p>

Liu Muqiao was unmoved. He wanted to make the "China" journal a success. Now, the "China" journal has reached the first place in the comprehensive ranking.

To maintain this throne, we cannot do without Liu Maqiao’s support.

In the end, Dr. M gave up and returned to China with this result, and Yuan Shan became the vice president of the "International Professional Committee on Obesity". The president is Dr. George Ying, a Nobel laureate in medicine and physiology.

He has made outstanding achievements in obesity gene research and is also a master-level scholar in "life sciences". No one will object to his appointment as chairman.

Director Yuan won her first international title, and the next step was easy. As the patients she treated successfully lost weight one by one, her fame naturally grew.

Soon, she received professorships from three well-known universities, and these three universities were all from abroad.

Obesity is an international problem, especially in Western countries. There are too many obese people. If they are asked to exercise to lose weight, they will be too lazy to move even if they die tomorrow.

Yuan Shan applied for the five prepared prescriptions to be hospital preparations and entrusted Liu Maqiao's pharmaceutical factory to help her produce them. The hospital held 40% of the shares and she held 60% of the five preparations.

Originally, this share should belong to Liu Miqiao.

Liu Muqiao didn't ask for shares. He said that if Yuan Shan could make some money, he would just earn some processing fees.

In fact, Liu Muqiao's pharmaceutical factory has already made money during the production process, so there is no need to make another profit.

Yuan Shan used to envy Zhao Yilin the most because he had a large stake in Liu Muchiao Pharmaceutical Factory. Now, she also has a money tree.

There is no need to envy Zhao Yilin. From now on, you will not earn less than Zhao Yilin. You must know how big the obesity market is.

But, then again, the shares allocated this time are only 5 prescription hospital preparation shares.

Hospital preparations and quasi-brand medicines are different.

Drugs with accurate brand names are regular drugs and can be circulated in the market.

Hospital preparations can only be used in hospitals, that is to say, only patients who are receiving treatment in the hospital can take this medicine.

That is to say, Yuan Shan can make a fortune, but she cannot become a billionaire. The medicine prescribed from her will make her a multimillionaire at most.

In the future, if her hospital preparation is approved as a standard brand drug, it is impossible not to give Liu Miqiao shares, and Liu Miqiao will not be stupid and refuse it.

Liu Muqiao is sometimes stupid, but not always stupid.

As Yuan Shan was hired as a professor from abroad, Antai Hospital suddenly had many fat foreigners.

It can be said that fat people gather here.

White fat people and black fat people can be seen casually in Antai Hospital.

Yuan Shan couldn't laugh or cry.

The clinic she attended was the "Children's Obesity Clinic", but half of the patients were adults, and many of them were 60-year-olds.


This chapter has been completed!
PreviousBack to directoryNext